Targeted therapy for LIMD1-deficient non-small cell lung cancer subtypes

Targeted therapy for LIMD1-deficient non-small cell lung cancer subtypes

Abstract An early event in lung oncogenesis is loss of the tumour suppressor gene LIMD1 (LIM domains containing 1); this encodes a scaffold protein, which suppresses tumorigenesis via a number of different mechanisms. Approximately 45% of non-small cell lung cancers (NSCLC) are deficient in LIMD1, y...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kathryn Davidson, Paul Grevitt, Maria F. Contreras-Gerenas, Katherine S. Bridge, Miguel Hermida, Kunal M. Shah, Faraz K. Mardakheh, Mark Stubbs, Rosemary Burke, Pedro Casado, Pedro R. Cutillas, Sarah A. Martin, Tyson V. Sharp
Format: article
Langue:EN
Publié: Nature Publishing Group 2021
Sujets:
Cytology
QH573-671
Accès en ligne:https://doaj.org/article/006a5cc989ef440e83fa93a4ded65708
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/006a5cc989ef440e83fa93a4ded65708

Documents similaires